Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Peijia Medical (9996 HK)
Watchlist
72
Analysis
Health Care
•
China
Peijia Medical Ltd. produces and sells medical devices. The Company develops and sells heart valve disease treatment medical devices and other products. Peijia Medical Technology markets its products throughout China.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Microport Scientific
•
21 Mar 2022 09:03
Microport Scientific (853.HK) - The Subsidiaries Would Be a Better Investment
We analyzed the centralized procurement and other concerns on MicroPort. Due to its development mode, the subsidiaries are more attractive and...
Xinyao (Criss) Wang
Follow
302 Views
Share
bullish
•
Thematic (Sector/Industry)
•
20 Feb 2022 09:19
China Healthcare Weekly (Feb.18)-VBP Expansion, China Drug Pricing System,FDA Approval,Junshi/Legend
We analyzed the VBP scope expansion and logic of drug pricing system in medical insurance negotiation.FDA's attitude on Legend Bio&Junshi's...
Xinyao (Criss) Wang
Follow
211 Views
Share
bullish
•
HeMo Bioengineering
•
02 Feb 2022 09:14
Pre-IPO HeMo Bioengineering - Insights on Industry, Business and Concerns
We analyzed the industry characteristics, the business and competitive landscape of HeMo. The centralized procurement, commercialization...
Xinyao (Criss) Wang
Follow
295 Views
Share
bearish
•
Shanghai NewMed Medical
•
01 Feb 2022 09:13
Pre-IPO Shanghai NewMed Medical - Concerns on Fierce Competition and Future Commercialization
We analyzed the industry characteristics of heart valve device market. Concerns of NewMed are mainly the slow product development progress, fierce...
Xinyao (Criss) Wang
Follow
281 Views
Share
bullish
•
Peijia Medical
•
25 Jan 2022 09:11
Peijia Medical (9996.HK) Vs Venus MedTech (2500.HK) Vs CardioFlow (2160.HK)-Pain Points and Solution
We analyzed the TAVR business of Venus, MicroPort CardioFlow and Peijia. We also analyzed the competition pattern, concerns, pain points of TAVR...
Xinyao (Criss) Wang
Follow
222 Views
Share
First
Previous
1
2
3
4
5
6
7
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.33.9
x